MON - SAT : 9:30 AM to 6:00 PM

The prerequisite for forming a profitable Gastro and PPI PCD Franchise depends upon choosing the right associate. The Indian market for gastro treatments, as well as gastrointestinal products, is continually growing because of lifestyle-related acidity, increasing cases of GERD and peptic ulcers, and increased consciousness about liver and gut health. This is the stage where Kivonyx Healthcare, after 44+ years of experience, comes in to provide a Gastro & PPI PCD Franchise based on profits, rather than hope.
Kivonyx Healthcare is a WHO-GMP & GMP-compliant pharma company that provides an exclusive Gastro & PPI PCD Pharma Franchise in India. Whether you are a seasoned MR trying to open your own business or a qualified pharmacist seeking additional income or even a fresher to enter the field of healthcare, our franchise program will provide you with guaranteed profit from your investments, which initially are relatively small.
With every gastro & PPI franchisee that we add to our network, we will provide them with area monopoly rights, all the promotional tools required, Relationship Manager services, and an array of acid reflux, ulcer, liver health, and antiemetic SKUs, all without any hidden charges or surprises.
Kivonyx Healthcare Pvt. Ltd. is a research-oriented and quality-first pharmaceutical company with GMP-certified manufacturing facilities. A single-minded ideology has always guided us — when our franchising partners grow, we grow as well — and this is how we are able to establish an excellent network of franchise partners in the area of digestive health. The segment of gastro and PPI is still one of our main categories in 2025-26 due to high prescribing in cases of acidity, GERD and other digestive disorders associated with lifestyle.
We are producing and distributing capsules, tablets and suspensions in the field of gastroenterology and hepatoprotection, all of which are WHO-GMP and DCGI approved. All batches are subjected to strict quality control and testing and are available with Certificate of Analysis (CoA) reports on request.

Our comprehensive range of gastro products and medicines is able to subdue the signs and symptoms of heartburn, peptic ulcers, gastritis, and other digestive issues. Our PPI (Proton Pump Inhibitor) products aim to lower the gastric acid production to help patients suffering from GERD (Gastroesophageal Reflux Disease) and esophagitis.
Our PPI drugs are reliable and effective in reducing acid production, thereby providing relief from acid reflux and heartburn.
Our gastro range also includes medications that help in the treatment of peptic ulcers and also provide relief against their recurrence.
Our products are known for aiding digestive health. They improve overall gut health by resolving and treating various gastrointestinal issues, thus ensuring a healthy digestive system.
We provide highly functional and effective medicines to support liver function and overall health. Liver function is one of the most crucial aspects of a well-functioning digestive system.
Our product range also includes effective antiemetic medications to provide prompt relief from nausea and vomiting, and thus ensure patient comfort.
Our exclusive line of products in the gastro and PPI range makes us a preferred choice.
We have formulated highly potent medicines that provide maximum relief from various gastrointestinal disorders.
We always endeavor to maintain the continuous availability of our products at all times across different parts of the country.
Our dedicated team offers comprehensive customer and technical support.
We provide extensive marketing and promotional support to help our partners succeed.
Kivonyx Healthcare offers lucrative PCD franchise opportunities for Gastro & PPI Pharma in India through monopoly-based operations. All territory allotment is done on the first come first serve basis; once a particular region is allotted to one of our associates, no other Kivonyx associate will be assigned in that territory. We are now covering the following states and more:

| Feature | Kivonyx Healthcare | Generic Aggregator Listing |
|---|---|---|
| Monopoly Territory Rights | ✓ Yes, in writing | Often unclear or unenforced |
| WHO-GMP & ISO 9001:2015 Certified | ✓ Verified | Frequently unverified |
| Dedicated Relationship Manager | ✓ Yes | ✗ Rarely |
| Direct Manufacturer Pricing | ✓ Yes | Often routed through middlemen |
| Documented Terms & Renewal Policy | ✓ Yes | ✗ Rarely disclosed upfront |
During the entire period of the franchise contract, the partners cannot promote or market products of any other company whose products are competitive to those of Kivonyx in the same therapy segment without the written permission from Kivonyx Healthcare.
There are no restrictions when it comes to joining our franchise network; you don’t have to be a seasoned professional in the pharma industry to join our ranks:
All you need to join us is a valid license to sell drugs and a basic understanding of the market in your territory.
Our initial order usually begins between ₹15,000 – ₹25,000, varying by your chosen product segment and territory size — one of the lowest entry investments in the Indian PCD pharma franchise market.
Yes. You must possess a valid drug license from your state’s drug control authority — either a Form 20/21 (retail) or Form 20B/21B (wholesale) — to become a PCD pharma franchisee.
Yes, each Kivonyx gastro & PPI franchise partner is granted area-level monopoly rights. Once your territory is set by agreement, no other Kivonyx associate will be allotted there.
Your complimentary starter kit includes visual aids, MR bags, product brochures, visiting cards, prescription pads, sample packs, and doctor gifts to support your promotional work at no extra cost.
Orders are shipped within 5 to 7 business days of receiving payment and typically reach your delivery destination within 2 to 10 days depending on location.
Yes, we offer both single-segment and multi-segment gastro & PPI franchises, so you can expand your offering to gastroenterologists, physicians and pharmacies as your business grows.